Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer
- Resource Type
- Article
- Source
- In
Annals of Oncology May 2020 31(5):582-589 - Subject
Breast tumor - Language
- ISSN
- 0923-7534